WELLCARE HEALTH PLANS, INC. Balance Sheet

Ask AI

Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated balance sheets

In millions of USD, except per-share amounts

	Q3 FY2019 As of Sep 30, 2019	Q2 FY2019 As of Jun 30, 2019	Q1 FY2019 As of Mar 31, 2019	Q4 FY2018 As of Dec 31, 2018	Q3 FY2018 As of Sep 30, 2018	Q2 FY2018 As of Jun 30, 2018	Q1 FY2018 As of Mar 31, 2018	Q4 FY2017 As of Dec 31, 2017	Q3 FY2017 As of Sep 30, 2017	Q2 FY2017 As of Jun 30, 2017	Q1 FY2017 As of Mar 31, 2017	Q4 FY2016 As of Dec 31, 2016	Q3 FY2016 As of Sep 30, 2016	Q2 FY2016 As of Jun 30, 2016	Q1 FY2016 As of Mar 31, 2016	Q4 FY2015 As of Dec 31, 2015	Q3 FY2015 As of Sep 30, 2015	Q2 FY2015 As of Jun 30, 2015	Q1 FY2015 As of Mar 31, 2015	Q4 FY2014 As of Dec 31, 2014
Assets
Current Assets:
Cash and cash equivalents
Short-term investments
Premiums receivable, net
Pharmacy rebates receivable, net
Receivables from government partners
Funds receivable for the benefit of members
Income taxes receivable
Deferred ACA industry fee
Prepaid expenses and other current assets, net
Deferred income tax asset
Total current assets

Property, equipment and capitalized software, net
Goodwill
Other intangible assets, net
Long-term investments
Restricted cash, cash equivalents and investments
Other assets
Assets of discontinued operations
Total Assets
Liabilities and Stockholders' Equity
Current Liabilities:
Medical benefits payable
Unearned premiums
Accounts payable
Other accrued expenses and liabilities
ACA industry fee liability
Accounts payable and accrued expenses
Current portion of long-term debt, net
Current portion of amount payable related to investigation resolution
Funds payable for the benefit of members
Other payables to government partners
Income taxes payable
Total current liabilities

Deferred income tax liability
Amount payable related to investigation resolution
Long-term debt
Deferred income tax liability, net
Long-term debt, net
Other liabilities
Liabilities of discontinued operations
Total Liabilities
Commitments and contingencies (see Note 14)
Stockholders' Equity:
Preferred stock, $0.01 par value (20,000,000 authorized, no shares issued or outstanding)
Common stock, $0.01 par value (100,000,000 authorized, 50,316,099 and 49,993,219 shares issued and outstanding at September 30, 2019 and December 31, 2018, respectively)
Paid-in capital
Retained earnings
Accumulated other comprehensive income (loss)
Total Stockholders' Equity
Total Liabilities and Stockholders' Equity

Comments